Biotechnology Product Development Overview

A plan that helps determine if a product is worth making. It considers factors like market size, need, preliminary data, patent protection, and profitability.

A method of measuring the concentration, activity, and presence of a substance. It's essential for product development and quality control.

The process of using plant and animal parts as sources of products, applying scientific knowledge to extract useful materials.

Determining the effectiveness of antibiotics and antimicrobials by measuring their ability to inhibit the growth of bacteria.

A type of cell used in protein product development, particularly for producing therapeutic proteins.

A series of steps essential for producing recombinant DNA protein products, including gene cloning, cell expression, purification, and formulation.

Determining whether a product is needed, who will use it, and whether the market is large enough to support its sales.

Substances from natural sources, like animal organs or plants, often used to create pharmaceuticals and healthcare products.

Amylase is an enzyme that breaks down starch into sugar. The activity of amylase can be observed by its ability to lighten the color of a starch/iodine mixture. The lighter the color, the more active the amylase.

ELISA stands for Enzyme-Linked Immunosorbent Assay. It's a highly specific molecular assay that identifies and measures concentrations of specific proteins or antigens in a mixture.

ELISA combines two important phenomena: 1) antibody-antigen specificity, which only recognizes very specific molecules and 2) enzyme activity on colorimetric reagents for visualization.

A Western blot is a technique used to identify and quantify proteins in a sample. Proteins are separated based on size on a gel, then transferred to a membrane. Antibodies, specific to the target protein, are used to visualize the protein's presence on the membrane.

In a Western blot, proteins are transferred from the PAGE gel to the blot transfer membrane using electrical current. This process moves the proteins from the gel to the membrane for further analysis.

Nutraceuticals are herbal remedies derived from food and plants that may provide pharmaceutical or nutritional benefits. These products often claim to have antimicrobial properties.

rDNA refers to recombinant DNA, which is DNA created by combining genetic material from two different sources. This technology allows for the production of proteins, such as insulin, in large quantities.

rDNA was first produced in the mid-1970s and has opened up new avenues for producing protein products. This technology has greatly impacted various fields, including medicine, agriculture, and biotechnology.